March 03, 2021, Wednesday
Cipla stock went up by almost 3 per cent on Tuesday
February 04, 2021, Thursday
Biocon Biologics is an arm of biotechnology major Biocon
January 22, 2021, Friday
Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional ...
January 29, 2020, Wednesday
Ramp-up and new biosimilars should help boost profit
January 24, 2020, Friday
The company is uniquely positioned in the US as it is the only Indian pharmaceutical firm with two commercialised biosimilars in ...
September 26, 2019, Thursday
Data shows while the overall biosimilars category has clocked a 10.3% value compound annual growth rate (CAGR) over the past few ...
July 29, 2019, Monday
Margins of biologics stood at 38% in Q1 as compared to 33% in the preceding quarter
February 19, 2017, Sunday
The demand for biosimilars is bound to increase with more complex biologics going off-patent
October 06, 2016, Thursday
The biosimilars opportunity is nascent today and the 2016 estimated market size was only $2.2 billion
Copyrights © 2021 Business Standard Private Ltd. All rights reserved.
Upgrade To Premium Services
Business Standard is happy to inform you of the launch of "Business Standard Premium Services"
As a premium subscriber you get an across device unfettered access to a range of services which include:
In Partnership with
Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.
Team Business Standard